Medication info
Sitagliptin Phosphate Hydrate 100 mg (Sitagliptin Phosphate Monohydrate)

Sitagliptin Phosphate Hydrate 100 mg (Sitagliptin Phosphate Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
JongKeunDang Co., Ltd.
Appearance
Beige round film-coated tablets
Packaging
PTP - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 201503476 · Approved 2015.05.29 · Insurance code 643307090

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This product is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This product may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dosage adjustment based on renal function may be necessary, renal function should be assessed before and periodically during treatment with this product. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This product may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
JongKeunDang Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood glucose control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to improve blood glucose control in patients with type 2 diabetes. It can be used alone; however, if monotherapy is insufficient for initial treatment, it can be used in combination with metformin. Additionally, when blood glucose control is difficult with sulfonylureas, metformin, thiazolidinedione, or insulin monotherapy, the medication can be co-administered to enhance therapeutic effects. For patients requiring complex medication regimens, it is added to combination therapies of sulfonylureas and metformin, or thiazolidinedione and metformin, or insulin and metformin. Its flexible usability in diverse situations effectively improves blood glucose control.

How to take

Adult dose

This product is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This product may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dosage adjustment based on renal function may be necessary, renal function should be assessed before and periodically during treatment with this product. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This product may be administered without regard to the timing of dialysis.

Precautions

This medication may cause severe allergic reactions in some patients; if symptoms such as skin rash, breathing difficulties, or swelling of the face or neck occur, discontinue use immediately and consult a healthcare professional. While taking this medication, symptoms of pancreatitis, which is inflammation of the pancreas, may occur, so if you experience abdominal pain, vomiting, or decreased appetite, you should visit a hospital immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, and it should be avoided if there is an allergy to this medication or its ingredients. Patients with impaired kidney function should adjust the dose of this medication, so if there are kidney diseases, consult a doctor to determine the appropriate dose. This medication can be used alone or in combination with other diabetes medications; however, when used with insulin or sulfonylureas, the risk of hypoglycemia may increase, so blood glucose levels should be monitored regularly and dose adjustments made as necessary. Pregnant or breastfeeding women are advised against using this medication, and safety in children and adolescents under 18 has not been established. Elderly patients may have reduced kidney function, so it is important to regularly check kidney function before and after taking this medication. In case of overdose, symptomatic treatment is necessary, and this medication may be partially removed through hemodialysis, so dialysis treatment may be considered in cases of severe overdose. If joint pain or skin blisters occur while taking this medication, inform a healthcare professional immediately for appropriate diagnosis and treatment. Additionally, side effects such as upper respiratory infections, headaches, indigestion, and diarrhea have been reported in some patients, so if abnormal symptoms persist, consult a healthcare professional. Lastly, this medication generally has few drug interactions but consulting a doctor or pharmacist when taking certain medications is advisable.

Side effects

Hypersensitivity, Anaphylaxis, Angioedema, Stevens-Johnson Syndrome, Exfoliative Dermatitis, Acute Pancreatitis, Hypoglycemia, Nasopharyngitis, Upper Respiratory Infection, Headache, Diarrhea, Abdominal Pain, Nausea, Peripheral Edema, Constipation, Vomiting, Severe and Disability-Associated Arthralgia, Bullous Pemphigoid, Myalgia, Limb Pain, Back Pain, Interstitial Lung Disease, Pruritus, Thrombocytopenia, Rhabdomyolysis, Elevated Liver Enzymes, Acute Renal Failure, Pneumonia, Diabetes Complications, Metabolic Acidosis, Falls, Cardiac Arrest, Dyspepsia, Dizziness, Increased Serum Triglycerides, Gastritis, Increased Low-Density Lipoprotein, Hyperglycemia, Weight Loss, Hypertension, Hypernatremia, Erectile Dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent the ingress of air or moisture, and it is best kept at temperatures between 1°C and 30°C at room temperature. Storing it this way helps maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Beige round film-coated tablets

Package unit

PTP - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.